Published online Feb 16, 2018. doi: 10.4253/wjge.v10.i2.56
Peer-review started: October 16, 2017
First decision: November 7, 2017
Revised: December 28, 2017
Accepted: January 15, 2018
Article in press: January 15, 2018
Published online: February 16, 2018
Processing time: 115 Days and 16.7 Hours
Hepatocellular carcinoma constitutes over 90% of the primary liver tumors, the rest being cholangiocarcinoma. It has an insidious presentation, which is responsible for the delayed presentation. Hence, the management strategy relies on screening to diagnose it an early stage for curative resection and/or treatment with local ablative techniques or chemotherapy. However, even with different screening programs, more than 60% of tumors are still detected at an advanced stage, leading to an unchanged mortality rate, thereby implying a room for improvement in the screening and diagnostic process. In the last few years, there has been evolution of utility of endoscopy, specifically endoscopic ultrasonography along with Fine needle aspiration, for this purpose, which we comprehensively review in this article.
Core tip: Hepatocellular carcinoma (HCC) constitutes the commonest primary liver cancer, and if diagnosed at an early stage, has better prognosis. Of late, there has been evolution of utility of endoscopic techniques, specifically endoscopic ultrasonography (EUS) with fine needle aspiration, for this purpose. EUS is superior over computed tomography in detecting hepatic lesions smaller than 1cm, and also allows FNA for accurate histopathological diagnosis. This strategy is particularly useful for indeterminate nodules, with non-specific imaging characteristics. Role of EUS in diagnosis and management of HCC are the focus of this article. In addition, other endoscopic techniques, including esophagogastroduodenoscopy and endoscopic retrograde cholangio-pancreatography, are of immense use in management of complications of HCC, which are also briefly discussed in this review.